Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 15 of 15 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Propella Therapeutics Inc. | Activity: Research and Development | Company Description Propella Therapeutics has developed a platform which combines lymphatic targeting with a medicinal chemistry optimization process to create therapeutics for cancer. The lead asset is PRL-02 (abiraterone decanoate) for prostate cancer. | Location Pittsboro | |
Company Affinergy LLC | Activity: Research and Development | Company Description Affinergy develops diagnostic tools for rare and difficult to diagnose diseases. Affinergy's development programs include rapid assays for proteins, drugs, cells and small molecules. | Location Durham | |
Company Arthrolax Solutions | Activity: Research and Development | Company Description Arthrolax Solutions develops devices for the treatment and prevention of joint injuries. | Location Greensboro | |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest | |
Company CytexOrtho | Activity: Research and Development | Company Description CytexOrtho develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases. | Location Durham | |
Company Doron Therapeutics | Activity: Research and Development | Company Description Doron Therapeutics is developing an injectable biologic to treat osteoarthritis and other musculoskeletal diseases. | Location Chapel Hill | |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham | |
Company Kartha Pharmaceuticals Inc. | Activity: Research and Development | Company Description Kartha Pharmaceuticals develops and commercializes pharmaceutical products. | Location Matthews | |
Company MitoRainbow Therapeutics Inc. | Activity: Research and Development | Company Description MitoRainbow is developing treatments for TK2 deficiency, a mitochondrial disease that manifests as severe myopathy. | Location Cary | |
Company ML Bio Solutions Inc. | Activity: Research and Development | Company Description ML Bio Solutions is developing an oral treatment for patients with limb girdle muscular dystrophy 2i. | Location Charlotte | |
Company OsteoCure Therapeutics Inc. | Activity: Research and Development | Company Description OsteoCure Therapeutics develops novel treatments to accelerate and promote bone fracture healing and prevent nonunions. | Location Durham | |
Company Plakous Therapeutics Inc. | Activity: Research and Development | Company Description Plakous Therapeutics developed a cell-free placenta extract to prevent necrotizing enterocolitis in premature babies. The cytokines and growth factors purified in the product have anti-inflammatory, regenerative, and immunomodulatory properties analogous to mid-pregnancy amniotic fluid. | Location Winston-Salem | |
Company Reselute Inc. | Activity: Research and Development | Company Description Reselute is developing a medical device for the treatment of orthopedic implant related infections. | Location Durham | |
Company SP Innovations LLC | Activity: Research and Development | Company Description SP Innovations is developing a graft for irreparable rotator cuff tendon injuries. | Location Raleigh | |
Company Sparta Biomedical Inc. | Activity: Research and Development | Company Description Sparta Biomedical is developing cartilage-like implants to mimic the properties of native cartilage and address degeneration in joints. | Location Morrisville |